Report from the 4th Advances Against Aspergillosis Conference

Future Microbiology
Donald Sheppard, Liz McNeil Grist

Abstract

Traditionally, the patients believed to be at highest risk of invasive aspergillosis (IA) are those who are neutropenic due to chemotherapy for hematological malignancy or those undergoing allogeneic hematopoietic stem cell transplantation. However, emerging data show that other patients are vulnerable to IA, even though some are not classically immunocompromised. These include: solid organ transplant recipients; patients with TB, chronic obstructive pulmonary disease and patients in the intensive care unit for other reasons. The conference highlighted the diagnostic and therapeutic challenges facing physicians treating this diverse group, not least of which include the unreliable estimates of IA incidence due to poor surveillance and inadequate data collection. Moreover, although there is now considerable experience of IA in neutropenic patients, much less is known about the management of those who are non-neutropenic. Nevertheless, approaches that have proven effective in neutropenic patients may also benefit others in this growing population. The meeting, attended by more than 500 delegates from almost 50 countries, also provided the opportunity to hear how basic scientific research may improve the understanding of the patho...Continue Reading

References

Jan 26, 2007·The New England Journal of Medicine·Oliver A CornelyDavid Angulo-Gonzalez
Sep 30, 2008·Applied and Environmental Microbiology·Matthias BrockOumaïma Ibrahim-Granet
Jan 28, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N SinghUNKNOWN AST Infectious Diseases Community of Practice
Jun 3, 2010·Antimicrobial Agents and Chemotherapy·John E ConteJeffrey A Golden

❮ Previous
Next ❯

Citations

Apr 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David W DenningDavid S Perlin
Jan 25, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dimitrios P KontoyiannisThomas J Walsh

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
lavage

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.